Jared Freedberg serves as Executive at INTERCEPT PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Jared Freedberg has executed 14 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 8, 2023 involved transacting 22,681 shares valued at $430.9K.
Jared Freedberg currently holds 56,443 shares of INTERCEPT PHARMACEUTICALS, INC. (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jared Freedberg has been a net neutral trader of ICPT stock. They have purchased $0 and sold $0 worth of shares.
Jared Freedberg's most recent insider trade was on Nov 8, 2023, when they sold 22,681 shares at $19.00 per share.
Get notified when new Form 4 filings are submitted
| 33,762 |
| $19.00 |
| Discretionary |
| Nov 1, 2023 | ICPT | $14.6K | Payment | 771 | $18.96 | Discretionary |
| Aug 1, 2023 | ICPT | $8.1K | Payment | 771 | $10.50 | Discretionary |
| May 1, 2023 | ICPT | $13.2K | Payment | 771 | $17.07 | Discretionary |
| Feb 1, 2023 | ICPT | $17.2K | Payment | 918 | $18.76 | Discretionary |
| Jan 27, 2023 | ICPT | $0 | Award | 12,200 | $N/A | Discretionary |
| Dec 31, 2022 | ICPT | $8.9K | Payment | 718 | $12.37 | Discretionary |
| Nov 1, 2022 | ICPT | $12.1K | Payment | 771 | $15.73 | Discretionary |
| Aug 1, 2022 | ICPT | $9.4K | Payment | 771 | $12.21 | Discretionary |
| May 1, 2022 | ICPT | $12.1K | Payment | 771 | $15.71 | Discretionary |
| Feb 1, 2022 | ICPT | $68.9K | Payment | 4,072 | $16.91 | Discretionary |
| Jan 27, 2022 | ICPT | $0 | Award | 10,300 | $N/A | Discretionary |
| Feb 1, 2021 | ICPT | $0 | Award | 44,277 | $N/A | Discretionary |